Davis's Drug Guide
** Update Information **
Latest Update
This resource was last updated on: 2021-11-9
New topics:
- lorlatinib
- magnesium sulfate (parenteral)
- nystatin (oral)
- olopatadine (nasal)
- rimegepant
- risankizumab
- romosozumab
- sarecycline
- siponimod
- tezacaftor/ivacaftor
- tirbanibulin
- tivozanib
- trastuzumab/hyaluronidase
- trifarotene
- trilaciclib
- tucatinib
- ubrogepant
- upadacitinib
- voclosporin
- voxelotor
Changed topics:
- bendamustine
- celecoxib
- DOPamine
- dupilumab
- edoxaban
- elexacaftor/tezacaftor/ivacaftor
- empagliflozin/linagliptin
- enzalutamide
- ePHEDrine
- ESTRADIOL
- etodolac
- etravirine
- fenofibrate
- fenofibric acid
- fenoprofen
- ferric carboxymaltose
- flurbiprofen†
- glecaprevir/pibrentasvir
- HYDROcodone
- hydroxychloroquine
- ibalizumab
- ibuprofen
- NPH insulin (isophane insulin suspension)
- ketoprofen
- ketorolac†
- larotrectinib
- ledipasvir/sofosbuvir
- letrozole
- levamlodipine
- levETIRAcetam
- levocetirizine
- levoFLOXacin
- levomilnacipran
- levorphanol
- levothyroxine
- LIDOCAINE
- lidocaine/prilocaine
- liraglutide
- lithium
- lomitapide
- lomustine
- lopinavir/ritonavir
- loratadine
- LORazepam
- lorlatinib
- lubiprostone
- luspatercept
- lusutrombopag
- lutetium lu 177 dotatate
- macitentan
- magnesium sulfate (parenteral)
- malathion
- maraviroc
- mecasermin
- mechlorethamine (topical)
- meclizine
- meclofenamate
- medroxyPROGESTERone†
- meloxicam
- memantine
- meperidine
- mercaptopurine
- metFORMIN
- methohexital
- methotrexate
- metoclopramide
- metOLazone
- metoprolol
- metreleptin
- micafungin
- midazolam
- midostaurin
- miFEPRIStone
- miglustat
- miltefosine
- mirabegron
- mirtazapine
- mitoMYcin
- mitotane
- mometasone (inhalation)
- mometasone (nasal)
- montelukast
- morphine
- moxidectin
- mycophenolate mofetil
- nabumetone
- naftifine
- nalbuphine
- naloxegol
- naloxone
- naltrexone (oral)
- naproxen
- naproxen/esomeprazole
- natalizumab
- nebivolol
- nelfinavir
- neostigmine
- neratinib
- netupitant/palonosetron (oral)
- niacin
- NICOTINE
- NIFEdipine
- nilotinib
- nilutamide
- niMODipine
- nintedanib
- niraparib
- nitazoxanide
- NITROGLYCERIN
- nitroprusside
- norepinephrine
- nystatin (oral)
- obeticholic acid
- obiltoxaximab
- obinutuzumab
- ocrelizumab
- octreotide
- ofatumumab
- OLANZapine
- olaparib
- oliceridine
- olmesartan
- olopatadine (nasal)
- olsalazine
- omacetaxine
- omadacycline
- omalizumab
- ombitasvir/paritaprevir/ritonavir/dasabuvir
- omega-3-acid ethyl esters
- omeprazole
- onabotulinumtoxinA
- ondansetron
- oritavancin
- osimertinib
- oxaliplatin
- oxaprozin
- oxazepam
- OXYBUTYNIN
- oxyCODONE
- oxyMORphone
- ozanimod
- PACLitaxel
- palifermin
- paliperidone
- palonosetron
- pancrelipase
- pantoprazole
- pasireotide
- patiromer
- PAZOPanib
- pegfilgrastim
- peginterferon alfa-2a
- peginterferon beta-1a
- pembrolizumab
- PEMEtrexed
- pentosan
- perampanel
- pertuzumab
- phentermine/topiramate
- phenylephrine
- phenytoin
- pimavanserin
- pioglitazone
- piperacillin/tazobactam
- plecanatide
- polyethylene glycol 3350
- posaconazole
- pregabalin
- progesterone
- prucalopride
- pyrazinamide
- QUEtiapine
- dolasetron
- indacaterol
- ingenol
- mechlorethamine
- methyldopa
- rofecoxib
- tenapanor
- valdecoxib
** Update Information ** is a sample topic from the Davis's Drug Guide.
To view other topics, please log in or purchase a subscription.
Davis’s Drug Guide for Nurses App + Web from F.A. Davis and Unbound Medicine covers 5000+ trade name and generic drugs. Includes App for iPhone, iPad, and Android smartphone + tablet. Handbook covers dosage, side effects, interactions, uses. Davis Drug Guide PDF. Complete Product Information.
Citation
Vallerand, April Hazard., et al. "** Update Information **" Davis's Drug Guide, 16th ed., F.A. Davis Company, 2020. Davis's Drug Guide - OLD - USE 2.0, www.drugguide.com/ddo/view/Davis-Drug-Guide/50998/0/___Update_Information___.
Vallerand AHA, Sanoski CAC, Quiring CC. ** Update Information ** Davis's Drug Guide. F.A. Davis Company; 2020. https://www.drugguide.com/ddo/view/Davis-Drug-Guide/50998/0/___Update_Information___. Accessed January 21, 2022.
Vallerand, A. H., Sanoski, C. A., & Quiring, C. (2020). ** Update Information ** In Davis's Drug Guide (16th edition). F.A. Davis Company. https://www.drugguide.com/ddo/view/Davis-Drug-Guide/50998/0/___Update_Information___
Vallerand AHA, Sanoski CAC, Quiring CC. ** Update Information ** [Internet]. In: Davis's Drug Guide. F.A. Davis Company; 2020. [cited 2022 January 21]. Available from: https://www.drugguide.com/ddo/view/Davis-Drug-Guide/50998/0/___Update_Information___.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - ** Update Information **
ID - 50998
A1 - Sanoski,Cynthia A,
AU - Vallerand,April Hazard,
AU - Quiring,Courtney,
BT - Davis's Drug Guide
UR - https://www.drugguide.com/ddo/view/Davis-Drug-Guide/50998/0/___Update_Information___
PB - F.A. Davis Company
ET - 16
DB - Davis's Drug Guide - OLD - USE 2.0
DP - Unbound Medicine
ER -